Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Trading dude whats up its been years to see you post.
I ve been following $CYDY for years looking to maybe get few lottos below .30c if we get there again. At this point in time I am on the sideline too much risk for them to go BK at this juncture.
Wow just wow. Answer to my question for years why $CYDY could never get institutional funding. I did say it as speculation but it’s in black and white here. Exhibition 73.
73.
11 to operate. However, the Company’s leadership, in particular Pourhassan, repeatedly created
12 complications and impediments to funding. Basic background research on Pourhassan indicates
13 two filings for Chapter 7 Bankruptcy (in 2001 and 1991) as well as multiple criminal charges
14 and/or convictions, between 1986 and 2006. Moreover, Pourhassan had no apparent training,
15 experience or background in the medical or pharmaceutical field, prior to joining CytoDyn.
16 74. Pourhassan’s role as CytoDyn’s CEO has prevented the Company from obtaining
17 funding from institutional investors. In April 2018, Goldman Sachs Partners Fund informed
18 CytoDyn that it would not do business with CytoDyn unless Pourhassan was replaced. In
19 November 2018, Ziff Capital Partners and Bain Capital were prepared to invest $30 million each,
20 but chose not to do so because of Pourhassan.
21 75. Further, in December 2018/January 2019, Jason Silvers (“Silvers”) of Goldman,
22 Sachs & Co.’s Health Care and M&A Groups indicated that he was willing to work to help
23 CytoDyn raise capital from institutional investors, but during the course of discussions, it
24 became clear that Silvers did not want to work with Pourhassan.
$CYDY if you go back to my previous post from few months back u will see my .50c price prediction. CYDY is backed in to a corner.
Nader is too dumb to figure this out but here Nader you need to find a cash rich company like $FBRX $232m on the balance sheet. Merge with them since they have a failed trail and lots of $$$$. Problem solved. But he doesn’t have the business acumen to strategies M&A and he will be let go so not in his best interest.
This very well may be the last few months of $CYDY very bad situation Nader put all eggs on Covid and forgot about the core mission of pro 140.
Well we can agree that management is working on my side. I would like to buy shares but looking for a price point of at least .70 to jump in. I think the way stock price is trending it could dip below $1 by September.
This 13D group is getting kind of messy. BOD is really fighting back. I have no idea how Nader plans on raising capital and who would be willing to lend it to the firm after the Covid fumble.
I still think that CYDY should perhaps scrap the Covid trail reduce capital burn rate and focus on its primary goal of getting BLA approval for Combination HIV therapy. Wasted money and time chasing Covid-19. Could not secure one grant from Feds to advance the science or a philanthropist.
With the current cash reserve they can handle legal fees while the company tires to get something commercialized and in the hands of clients.
Vancouver pharmaceutical company CytoDyn says it’s under federal investigation over COVID-19 treatment claims
Link: https://news.google.com/articles/CAIiECZwqz_PaUG_lPUTgf-77IEqGQgEKhAIACoHCAownqX_CjCltfgCMJm5pAY?hl=en-US&gl=US&ceid=US%3Aen
Not a great look for Mr. Nader and team.
I am sure. I am actually just standing by waiting for the price to drop back under one and I will pick up 100-200k shares maybe. This should be a wake up call to management that they need to deliver something material or they will be fired.
Best of luck to all!
New CNBC CYDY article. New BOD is very well possible.
Link: https://news.google.com/articles/CAIiEKKxz_lZ7Df62o42JMM9GwEqGQgEKhAIACoHCAow2Nb3CjDivdcCMN74ngY?hl=en-US&gl=US&ceid=US%3Aen
Your welcome to do what you please. I cashed out and am not against Nader to be honest he delivered for me. I sold my last 12,000 shares just under $10@ $9.94. It was wonderful. But in order for me to buy back in I think it’s time for a change otherwise I dk who is going to continue funding CYDY they need fresh management.
Just saw the 13D group. If you want to save the little money you have left as a CYDY investor you better vote the new board members in ASAP. Shareholders have a chance to put a wedge into a sinking ship and stop the leak. CYDY is really in dangerous waters now and could go bankrupt this time. IMO only
CYDY back on my watchlist I will have the buy order ready at .50c. If it breaks a dollar it’s going down hard after that. Hope y’all cashed out when you had the chance. I can’t speak poorly about Nader he made me a millionaire.
Remember folks just buy the dip? Nevertheless, good luck to all.
You could of taken $9 and $10 like I did. And I still read the board waiting to jump back in when price is more attractive.
For shareholder edification. ViiV’s HIV prevention shot beats Gilead’s widely used pill in a study of women
Link: https://www.statnews.com/pharmalot/2020/11/09/hiv-aids-glaxo-pfizer-truvada/
The problem here is not that Leronlimab doesn’t have the potential to be effective but it should be obvious FDA is controlled by BP and they won’t let CYDY on the table. The saving grace for long share holders is for CYDY to get approval for something at least some revenue generated and a buyout from BP. Otherwise Nader will be raising funds here soon at .75c again with warrants.
$2 will break IMO. Nader can’t even file a BLA right. Covid stocks have ran their course Its time focus on the core indications and get some revenue generated.
The chart looks like it wants to roll over. We are making lower highs. But seems like every lower point buyers step in. I see the price retracing to the lower $2s since it will be a while until something tangible comes out of $CYDY.
Been spot on with a lot of my analysis. Anyhow I appreciate your contribution always!!! Hope you did take some profit too. I hope you had few hundred thousand shares accumulated over the years. Next fund rise would be interesting to see what the price goes down to.
He is waiting for $1 just like I am.
No worries I still hold 50K position here. I would like to find a buying opportunity again hopefully as the FDA gives CYDY a PDUFA. Maybe 2021 Q2.
Hope you were not the one who bought my 200,000 shares at $9.
Won’t bother replying to you again but keep holding the bag.
Plenty of DD has been done on the company we are past that. Only thing left is for them to execute on approval for HIV BLA looks like won’t be complete until 2021. I would feel a lot more warm and fuzzy if CYDY had a PDFUA date. Can Nader at least get that done. I would like to buy new shares in the $1 range or even lower the way Nader is executing we could dip to that price point. I have only about 50,000 shares left so still a good chunk of cash go Nader.
Why confused - your analogy was spot on. Nader is CYDY.
At this point and share price at $2s range market is discounting Covid as a bust. CYDY should focus on getting the BLA for Combo through the regulatory process they can’t even do that. I really hope you took some profits in the $9 range.
Ppl need to be very careful here with Nader. He cashed out millions and even though he made a small fortune for many investors he holds all of the leverage now. No longer is he a broke CEO he is a multi millionaire now too. He can just quit as CEO and CYDY is going to the toilet. I am a buyer in the $1 range I believe price can get there absolutely.
I am a buyer of CYDY in the l1st. Where is Nader with the BLA submission. He has really enriched himself and good on him for the recent share rewards. He had made lots of $$$ for me so no complaining here
Hey Lawman hope you are well. I do hope you cashed out some shares. I was able to sell my investment in the $8 -$9 range and unload most as CYDY had it’s run up. Nader is still at it B.Sing. Nader pretty much tactically failed to capitalize on the share price run by raising funds also trading on OTC yada yada. His flaw is that he is a (greedy used car salesmen) and cashed out shares at the first chance like NKLA s CEO.
I believe the volume is mostley from short sellers. I took a starter pack below @2.94. Will add 1000 shares at a time. What did Nader do now?
Just to get back to speed here. What is the deal with the BLA and PDUFA date from the FDA? Has CYDY solved the issues that were raised by FDA I have not seen any PR about submitting the missing data that was requested? We are inching towards September if Nader does not furnish the data they asked for soon it could be Q1 of 2021 before Leronlimab is up for decision.
Only if she had Grammarly installed on her Web Browser it would have caught the errors. Looking to buy shares below $3. I have very small position left at the moment, I did not trust in Nader enough once he cashed out shares not to take profit too.
I would caution all to take Naders timelines and add weeks for margin of realism. Up listing from OTC will take several months BLA approval for HIV combination therapy may be in 2021 it’s already July. So unless Covid trials work out share price will be stuck in this lower bound range for now. Short sellers are on full attack mode and will only intensify their criticism as share price increases.
Also they should of dropped an offering at all-time highs secured financing. Now, they have to offer shares at $3 with warrants again which will dropped price more, unless Covid results are amazing in a few weeks.
Picked up under $3 great buy want more cheap shares plz shorts to bring it down so we can load more.....
Shorts are about to get free lunch. Glad that I cashed out 200k shares at $7, $8 $9. FDA crony political BP puppets must be getting major lobbies and board positions for messing with CYDY. Or just Nader is incompetent which is true too. O well I will reload today.
Trend, we are selling off until news comes out, we need funding soon and I am expected them to get some offers out too and that won't help the share price near term, but CYDY is a long term for me so I can wait. . Shorts and sellers are in control, I have my 10,000k share order close to $4, and then from there. Let's see.
I am looking to add more under $4. which we could hit here soon the way this are trending.
Twitter is a littered with record P&L s from all of the shorts. I did buy some in the long term account on the dip. Go CYDY!!!
Its simple what happened today. CYDY was overheated and too extended to the up side. It had an amazing run past week. It may continue but I am expecting more volatility in the next few trading secessions.
Remember CYDY is a COVID stock right now that’s what most believe so INO was down 20% just about until the close.
The price dropped to $4.50 because there was just no support no buyers were coming in and short sellers keeps selling and covering as the stock made new lows. We at least now have several areas of solid support established $5.50 is the area to watch now. $8 is major resistance since we couldn’t not break above it after the short sell off.
It also doesn’t help that CYDY is OTCB Robinhood investors are left out of this party plus ETFs institutions funds you name it OTC is not where we should be trading.